에이비스

PathoAID - BREAST

AI solution for analyzing H&E stained tissue slides,
the gold standard for cost-effective histopathology image analysis.

PathoAID - BREAST assists pathologists in predicting breast
cancer treatment and prognosis by deriving medical information unseen by human eye.

에이비스_pathoway

An AI-driven diagnostic solution for breast cancer, based on H&E stained tissue analysis.

A solution that utilizes artificial intelligence-based analysis of H&E staining, the fundamental biopsy assessment

method, to assists in breast cancer diagnosis, eliminating the need for IHC staining.


Medical professionals can render diagnoses in a time-efficient and cost-effective manner.
dark_gradeScore

1

A solution to predict biomarker status and cancer grade, and quantify breast cancer recurrence risk.

Predicting biomarkers such as ER, PR, HER2, and Ki-67, along with histologic grades of cancer, allows for providing a numerical indication of the degree of expression and the risk of recurrence.
The objective figures generated by PathoAID - BREASTempower medical professionals to render diagnoses more effectively.
2

A solution for segmenting and visualizing breast cancer histopathology images.

Facilitates the visualization and revelation of significant regions within histopathology images, presenting heatmaps that aid in the identification of areas which may pose challenges for visual discernment.

The visualization enables medical professionals to indentify aberrant areas and to enhance the accuracy and the swiftness of their diagnostic processes.

에이비스_breast_visual에이비스_breast_visual에이비스_breast_visual

PathoAID - BREAST 's Suggestion

Hormonal Therapy

Radiation Therapy

Chemo Therapy

Targeted Therapy

3

A solution assisting in determining the most suitable course of treatment.

PathoAID - BREAST facilitates the decision-making process for medical professionals to determine the optimal treatment for patients by utilizing pathology image analysis.

Contact US

For inquiries about our solutions or any other questions, please reach out.

I fully understand and agree to the company's mandatory, optional, and general collection and use of personal information.